The global Orally Disintegrating Tablet market size was valued at USD 14290 million in 2022 and is forecast to a readjusted size of USD 30040 million by 2029 with a CAGR of 11.2% during review period.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 40%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.
This report is a detailed and comprehensive analysis for global Orally Disintegrating Tablet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Orally Disintegrating Tablet market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Orally Disintegrating Tablet market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Orally Disintegrating Tablet market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Orally Disintegrating Tablet market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Orally Disintegrating Tablet
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Orally Disintegrating Tablet market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Strengths:
- Increased patient compliance due to ease of administration, particularly for elderly and pediatric populations.
- Growing demand for convenient, portable drug delivery systems in chronic disease management.
Weaknesses:
- Limited range of drug formulations that can be adapted for orally disintegrating tablets.
- Higher manufacturing costs associated with the production of ODTs compared to traditional tablets.
Opportunities:
- Expanding pipeline of novel drugs being developed as ODTs, particularly in neurology and psychiatry.
- Rising adoption of personalized medicine and increasing demand for patient-centric drug delivery systems.
Threats:
- Regulatory challenges related to the approval of ODT formulations, especially for novel drugs.
- Intense competition from alternative drug delivery systems, such as liquid formulations or transdermal patches.
Political:
- Regulatory frameworks in different regions may impact the approval and market entry of new ODT formulations.
- Government healthcare policies promoting patient-centered care may drive demand for more convenient drug delivery systems.
Economic:
- Rising healthcare costs may push pharmaceutical companies to seek cost-effective drug delivery solutions like ODTs.
- Economic downturns could limit healthcare spending, affecting the growth of the ODT market.
Sociocultural:
- Increasing consumer preference for user-friendly drug forms, particularly among the elderly and pediatric populations.
- Awareness campaigns promoting the benefits of ODTs can drive adoption in emerging markets.
Technological:
- Advances in pharmaceutical manufacturing technologies are enabling the production of high-quality ODTs with better drug stability.
- Innovations in taste-masking and disintegration technology are expanding the range of drugs suitable for ODT formulations.
Environmental:
- Growing pressure on the pharmaceutical industry to adopt sustainable packaging solutions for ODT products.
- Environmental concerns may lead to regulatory restrictions on plastic use in packaging, influencing ODT manufacturers.
Legal:
- Intellectual property laws and patents on ODT technologies could limit market entry for new players.
- Strict regulatory standards on drug formulation and safety could increase the time and cost for ODT approval.
Suppliers:
- Pharmaceutical manufacturers providing active ingredients and excipients for ODT formulations.
- Technology providers offering specialized equipment for ODT production, such as tableting machines and packaging systems.
Inputs:
- Raw materials including active pharmaceutical ingredients (APIs), binders, and flavoring agents.
- Regulatory guidelines and standards for the formulation and safety of ODT products.
Processes:
- Development of ODT formulations, including stability testing, taste masking, and disintegration testing.
- Manufacturing processes such as compression, coating, and packaging of the final product.
Outputs:
- Orally disintegrating tablets with enhanced patient compliance due to ease of administration.
- Market-ready ODT products that meet regulatory requirements for safety and efficacy.
Customers:
- Healthcare providers and pharmacists who recommend ODTs for patient treatment.
- Patients seeking convenient and easy-to-consume drug delivery options, especially for chronic conditions.
Threat of New Entrants:
- High entry barriers due to the significant capital investment required for manufacturing and regulatory approvals.
- Established brands and patents in the ODT space limit the ability of new competitors to enter the market.
Bargaining Power of Suppliers:
- Limited number of specialized suppliers for excipients and advanced manufacturing technology may increase dependency.
- Supply chain disruptions or fluctuations in raw material costs could impact production timelines and pricing.
Bargaining Power of Buyers:
- Increasing patient demand for convenience and ease of use strengthens the negotiating power of buyers.
- Healthcare providers and insurance companies exert pressure on pricing and cost-effectiveness of ODT products.
Threat of Substitutes:
- Liquid formulations, capsules, or transdermal systems offer alternative delivery methods, limiting market growth for ODTs.
- Generic ODT versions of branded drugs can reduce the market share of proprietary ODT products.
Industry Rivalry:
- Intense competition from both established pharmaceutical companies and new entrants developing ODT formulations.
- Price wars and innovations in drug delivery technologies create pressure on companies to differentiate their products.
Raw Material Suppliers:
- The availability and cost of key ingredients like active pharmaceutical ingredients (APIs), excipients, and taste-masking agents affect production costs.
- The need for specialized materials that facilitate rapid disintegration and stability, requiring reliable and high-quality suppliers.
Manufacturing Equipment Suppliers:
- Suppliers providing advanced tableting and coating machines are crucial for the large-scale production of ODTs.
- Technological advancements in machinery, such as equipment that ensures precise dosage and uniform disintegration, influence production efficiency.
Research & Development:
- R&D investments in improving the formulation and taste-masking technologies for ODTs are critical for developing market-leading products.
- Ongoing collaboration with academic institutions and industry experts drives innovation and addresses challenges like stability and scalability of ODT formulations.
Manufacturing & Production:
- The manufacturing process for ODTs requires specialized technology to ensure rapid disintegration and taste masking, which can be costly and complex.
- Scale-up challenges in production may impact the ability of companies to meet growing demand while maintaining product consistency and quality.
Quality Control & Regulatory Compliance:
- Ensuring ODTs meet regulatory standards (e.g., FDA, EMA) for bioavailability, stability, and safety is critical and can lead to increased costs and time delays.
- Continuous quality assurance practices are essential to guarantee that each batch meets the required specifications, affecting production efficiency and market entry speed.
Distribution & Supply Chain:
- Efficient distribution channels are essential to ensure timely delivery of ODT products to healthcare providers, pharmacies, and patients.
- Partnerships with third-party logistics companies and retail pharmacies are crucial for reaching end customers, especially in emerging markets.
Market Demand & Customer Segmentation:
- Increased patient demand for easy-to-consume medication, particularly among elderly and pediatric populations, is driving market growth.
- Growing adoption of ODTs in therapeutic areas like neurology and psychiatry presents opportunities to expand market reach across various medical specialties.
Chapter 1, to describe Orally Disintegrating Tablet product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablet, with price, sales, revenue and global market share of Orally Disintegrating Tablet from 2018 to 2023.
Chapter 3, the Orally Disintegrating Tablet competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orally Disintegrating Tablet breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Orally Disintegrating Tablet market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Orally Disintegrating Tablet.
Chapter 14 and 15, to describe Orally Disintegrating Tablet sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Orally Disintegrating Tablet
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Orally Disintegrating Tablet Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Anti-Psychotics Drug
1.3.3 Anti-Epileptics Drug
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Orally Disintegrating Tablet Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 CNS Diseases
1.4.3 Gastrointestinal Diseases
1.4.4 CVS Diseases
1.4.5 Others
1.5 Global Orally Disintegrating Tablet Market Size & Forecast
1.5.1 Global Orally Disintegrating Tablet Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Orally Disintegrating Tablet Sales Quantity (2018-2029)
1.5.3 Global Orally Disintegrating Tablet Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Orally Disintegrating Tablet Product and Services
2.1.4 Teva Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teva Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Orally Disintegrating Tablet Product and Services
2.2.4 Merck Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Recent Developments/Updates
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Orally Disintegrating Tablet Product and Services
2.3.4 Mylan Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mylan Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Orally Disintegrating Tablet Product and Services
2.4.4 Pfizer Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 Johnson and Johnson
2.5.1 Johnson and Johnson Details
2.5.2 Johnson and Johnson Major Business
2.5.3 Johnson and Johnson Orally Disintegrating Tablet Product and Services
2.5.4 Johnson and Johnson Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson and Johnson Recent Developments/Updates
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business
2.6.3 GSK Orally Disintegrating Tablet Product and Services
2.6.4 GSK Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GSK Recent Developments/Updates
2.7 Otsuka
2.7.1 Otsuka Details
2.7.2 Otsuka Major Business
2.7.3 Otsuka Orally Disintegrating Tablet Product and Services
2.7.4 Otsuka Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Otsuka Recent Developments/Updates
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business
2.8.3 Eli Lilly and Company Orally Disintegrating Tablet Product and Services
2.8.4 Eli Lilly and Company Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eli Lilly and Company Recent Developments/Updates
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business
2.9.3 AstraZeneca Orally Disintegrating Tablet Product and Services
2.9.4 AstraZeneca Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 AstraZeneca Recent Developments/Updates
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business
2.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Product and Services
2.10.4 Bristol-Myers Squibb Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bristol-Myers Squibb Recent Developments/Updates
2.11 Conquer
2.11.1 Conquer Details
2.11.2 Conquer Major Business
2.11.3 Conquer Orally Disintegrating Tablet Product and Services
2.11.4 Conquer Orally Disintegrating Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Conquer Recent Developments/Updates
3 Competitive Environment: Orally Disintegrating Tablet by Manufacturer
3.1 Global Orally Disintegrating Tablet Sales Quantity by Manufacturer (2018-2023)
3.2 Global Orally Disintegrating Tablet Revenue by Manufacturer (2018-2023)
3.3 Global Orally Disintegrating Tablet Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Orally Disintegrating Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Orally Disintegrating Tablet Manufacturer Market Share in 2022
3.4.2 Top 6 Orally Disintegrating Tablet Manufacturer Market Share in 2022
3.5 Orally Disintegrating Tablet Market: Overall Company Footprint Analysis
3.5.1 Orally Disintegrating Tablet Market: Region Footprint
3.5.2 Orally Disintegrating Tablet Market: Company Product Type Footprint
3.5.3 Orally Disintegrating Tablet Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Orally Disintegrating Tablet Market Size by Region
4.1.1 Global Orally Disintegrating Tablet Sales Quantity by Region (2018-2029)
4.1.2 Global Orally Disintegrating Tablet Consumption Value by Region (2018-2029)
4.1.3 Global Orally Disintegrating Tablet Average Price by Region (2018-2029)
4.2 North America Orally Disintegrating Tablet Consumption Value (2018-2029)
4.3 Europe Orally Disintegrating Tablet Consumption Value (2018-2029)
4.4 Asia-Pacific Orally Disintegrating Tablet Consumption Value (2018-2029)
4.5 South America Orally Disintegrating Tablet Consumption Value (2018-2029)
4.6 Middle East and Africa Orally Disintegrating Tablet Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Orally Disintegrating Tablet Sales Quantity by Type (2018-2029)
5.2 Global Orally Disintegrating Tablet Consumption Value by Type (2018-2029)
5.3 Global Orally Disintegrating Tablet Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Orally Disintegrating Tablet Sales Quantity by Application (2018-2029)
6.2 Global Orally Disintegrating Tablet Consumption Value by Application (2018-2029)
6.3 Global Orally Disintegrating Tablet Average Price by Application (2018-2029)
7 North America
7.1 North America Orally Disintegrating Tablet Sales Quantity by Type (2018-2029)
7.2 North America Orally Disintegrating Tablet Sales Quantity by Application (2018-2029)
7.3 North America Orally Disintegrating Tablet Market Size by Country
7.3.1 North America Orally Disintegrating Tablet Sales Quantity by Country (2018-2029)
7.3.2 North America Orally Disintegrating Tablet Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Orally Disintegrating Tablet Sales Quantity by Type (2018-2029)
8.2 Europe Orally Disintegrating Tablet Sales Quantity by Application (2018-2029)
8.3 Europe Orally Disintegrating Tablet Market Size by Country
8.3.1 Europe Orally Disintegrating Tablet Sales Quantity by Country (2018-2029)
8.3.2 Europe Orally Disintegrating Tablet Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Orally Disintegrating Tablet Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Orally Disintegrating Tablet Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Orally Disintegrating Tablet Market Size by Region
9.3.1 Asia-Pacific Orally Disintegrating Tablet Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Orally Disintegrating Tablet Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Orally Disintegrating Tablet Sales Quantity by Type (2018-2029)
10.2 South America Orally Disintegrating Tablet Sales Quantity by Application (2018-2029)
10.3 South America Orally Disintegrating Tablet Market Size by Country
10.3.1 South America Orally Disintegrating Tablet Sales Quantity by Country (2018-2029)
10.3.2 South America Orally Disintegrating Tablet Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Orally Disintegrating Tablet Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Orally Disintegrating Tablet Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Orally Disintegrating Tablet Market Size by Country
11.3.1 Middle East & Africa Orally Disintegrating Tablet Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Orally Disintegrating Tablet Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Orally Disintegrating Tablet Market Drivers
12.2 Orally Disintegrating Tablet Market Restraints
12.3 Orally Disintegrating Tablet Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Orally Disintegrating Tablet and Key Manufacturers
13.2 Manufacturing Costs Percentage of Orally Disintegrating Tablet
13.3 Orally Disintegrating Tablet Production Process
13.4 Orally Disintegrating Tablet Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Orally Disintegrating Tablet Typical Distributors
14.3 Orally Disintegrating Tablet Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Orally Disintegrating Tablet Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Orally Disintegrating Tablet Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Orally Disintegrating Tablet Product and Services
Table 6. Teva Orally Disintegrating Tablet Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Teva Recent Developments/Updates
Table 8. Merck Basic Information, Manufacturing Base and Competitors
Table 9. Merck Major Business
Table 10. Merck Orally Disintegrating Tablet Product and Services
Table 11. Merck Orally Disintegrating Tablet Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck Recent Developments/Updates
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Major Business
Table 15. Mylan Orally Disintegrating Tablet Product and Services
Table 16. Mylan Orally Disintegrating Tablet Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Mylan Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Orally Disintegrating Tablet Product and Services
Table 21. Pfizer Orally Disintegrating Tablet Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson and Johnson Major Business
Table 25. Johnson and Johnson Orally Disintegrating Tablet Product and Services
Table 26. Johnson and Johnson Orally Disintegrating Tablet Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Johnson and Johnson Recent Developments/Updates
Table 28. GSK Basic Information, Manufacturing Base and Competitors
Table 29. GSK Major Business
Table 30. GSK Orally Disintegrating Tablet Product and Services
Table 31. GSK Orally Disintegrating Tablet Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. GSK Recent Developments/Updates
Table 33. Otsuka Basic Information, Manufacturing Base and Competitors
Table 34. Otsuka Major Business
Table 35. Otsuka Orally Disintegrating Tablet Product and Services
Table 36. Otsuka Orally Disintegrating Tablet Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Otsuka Recent Developments/Updates
Table 38. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 39. Eli Lilly and Company Major Business
Table 40. Eli Lilly and Company Orally Disintegrating Tablet Product and Services
Table 41. Eli Lilly and Company Orally Disintegrating Tablet Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Eli Lilly and Company Recent Developments/Updates
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Major Business
Table 45. AstraZeneca Orally Disintegrating Tablet Product and Services
Table 46. AstraZeneca Orally Disintegrating Tablet Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. AstraZeneca Recent Developments/Updates
Table 48. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 49. Bristol-Myers Squibb Major Business
Table 50. Bristol-Myers Squibb Orally Disintegrating Tablet Product and Services
Table 51. Bristol-Myers Squibb Orally Disintegrating Tablet Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Bristol-Myers Squibb Recent Developments/Updates
Table 53. Conquer Basic Information, Manufacturing Base and Competitors
Table 54. Conquer Major Business
Table 55. Conquer Orally Disintegrating Tablet Product and Services
Table 56. Conquer Orally Disintegrating Tablet Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Conquer Recent Developments/Updates
Table 58. Global Orally Disintegrating Tablet Sales Quantity by Manufacturer (2018-2023) & (M Units)
Table 59. Global Orally Disintegrating Tablet Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Orally Disintegrating Tablet Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Orally Disintegrating Tablet, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Orally Disintegrating Tablet Production Site of Key Manufacturer
Table 63. Orally Disintegrating Tablet Market: Company Product Type Footprint
Table 64. Orally Disintegrating Tablet Market: Company Product Application Footprint
Table 65. Orally Disintegrating Tablet New Market Entrants and Barriers to Market Entry
Table 66. Orally Disintegrating Tablet Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Orally Disintegrating Tablet Sales Quantity by Region (2018-2023) & (M Units)
Table 68. Global Orally Disintegrating Tablet Sales Quantity by Region (2024-2029) & (M Units)
Table 69. Global Orally Disintegrating Tablet Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Orally Disintegrating Tablet Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Orally Disintegrating Tablet Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Orally Disintegrating Tablet Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Orally Disintegrating Tablet Sales Quantity by Type (2018-2023) & (M Units)
Table 74. Global Orally Disintegrating Tablet Sales Quantity by Type (2024-2029) & (M Units)
Table 75. Global Orally Disintegrating Tablet Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Orally Disintegrating Tablet Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Orally Disintegrating Tablet Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Orally Disintegrating Tablet Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Orally Disintegrating Tablet Sales Quantity by Application (2018-2023) & (M Units)
Table 80. Global Orally Disintegrating Tablet Sales Quantity by Application (2024-2029) & (M Units)
Table 81. Global Orally Disintegrating Tablet Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Orally Disintegrating Tablet Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Orally Disintegrating Tablet Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Orally Disintegrating Tablet Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Orally Disintegrating Tablet Sales Quantity by Type (2018-2023) & (M Units)
Table 86. North America Orally Disintegrating Tablet Sales Quantity by Type (2024-2029) & (M Units)
Table 87. North America Orally Disintegrating Tablet Sales Quantity by Application (2018-2023) & (M Units)
Table 88. North America Orally Disintegrating Tablet Sales Quantity by Application (2024-2029) & (M Units)
Table 89. North America Orally Disintegrating Tablet Sales Quantity by Country (2018-2023) & (M Units)
Table 90. North America Orally Disintegrating Tablet Sales Quantity by Country (2024-2029) & (M Units)
Table 91. North America Orally Disintegrating Tablet Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Orally Disintegrating Tablet Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Orally Disintegrating Tablet Sales Quantity by Type (2018-2023) & (M Units)
Table 94. Europe Orally Disintegrating Tablet Sales Quantity by Type (2024-2029) & (M Units)
Table 95. Europe Orally Disintegrating Tablet Sales Quantity by Application (2018-2023) & (M Units)
Table 96. Europe Orally Disintegrating Tablet Sales Quantity by Application (2024-2029) & (M Units)
Table 97. Europe Orally Disintegrating Tablet Sales Quantity by Country (2018-2023) & (M Units)
Table 98. Europe Orally Disintegrating Tablet Sales Quantity by Country (2024-2029) & (M Units)
Table 99. Europe Orally Disintegrating Tablet Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Orally Disintegrating Tablet Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Orally Disintegrating Tablet Sales Quantity by Type (2018-2023) & (M Units)
Table 102. Asia-Pacific Orally Disintegrating Tablet Sales Quantity by Type (2024-2029) & (M Units)
Table 103. Asia-Pacific Orally Disintegrating Tablet Sales Quantity by Application (2018-2023) & (M Units)
Table 104. Asia-Pacific Orally Disintegrating Tablet Sales Quantity by Application (2024-2029) & (M Units)
Table 105. Asia-Pacific Orally Disintegrating Tablet Sales Quantity by Region (2018-2023) & (M Units)
Table 106. Asia-Pacific Orally Disintegrating Tablet Sales Quantity by Region (2024-2029) & (M Units)
Table 107. Asia-Pacific Orally Disintegrating Tablet Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Orally Disintegrating Tablet Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Orally Disintegrating Tablet Sales Quantity by Type (2018-2023) & (M Units)
Table 110. South America Orally Disintegrating Tablet Sales Quantity by Type (2024-2029) & (M Units)
Table 111. South America Orally Disintegrating Tablet Sales Quantity by Application (2018-2023) & (M Units)
Table 112. South America Orally Disintegrating Tablet Sales Quantity by Application (2024-2029) & (M Units)
Table 113. South America Orally Disintegrating Tablet Sales Quantity by Country (2018-2023) & (M Units)
Table 114. South America Orally Disintegrating Tablet Sales Quantity by Country (2024-2029) & (M Units)
Table 115. South America Orally Disintegrating Tablet Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Orally Disintegrating Tablet Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Orally Disintegrating Tablet Sales Quantity by Type (2018-2023) & (M Units)
Table 118. Middle East & Africa Orally Disintegrating Tablet Sales Quantity by Type (2024-2029) & (M Units)
Table 119. Middle East & Africa Orally Disintegrating Tablet Sales Quantity by Application (2018-2023) & (M Units)
Table 120. Middle East & Africa Orally Disintegrating Tablet Sales Quantity by Application (2024-2029) & (M Units)
Table 121. Middle East & Africa Orally Disintegrating Tablet Sales Quantity by Region (2018-2023) & (M Units)
Table 122. Middle East & Africa Orally Disintegrating Tablet Sales Quantity by Region (2024-2029) & (M Units)
Table 123. Middle East & Africa Orally Disintegrating Tablet Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Orally Disintegrating Tablet Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Orally Disintegrating Tablet Raw Material
Table 126. Key Manufacturers of Orally Disintegrating Tablet Raw Materials
Table 127. Orally Disintegrating Tablet Typical Distributors
Table 128. Orally Disintegrating Tablet Typical Customers
List of Figures
Figure 1. Orally Disintegrating Tablet Picture
Figure 2. Global Orally Disintegrating Tablet Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Orally Disintegrating Tablet Consumption Value Market Share by Type in 2022
Figure 4. Anti-Psychotics Drug Examples
Figure 5. Anti-Epileptics Drug Examples
Figure 6. Others Examples
Figure 7. Global Orally Disintegrating Tablet Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Orally Disintegrating Tablet Consumption Value Market Share by Application in 2022
Figure 9. CNS Diseases Examples
Figure 10. Gastrointestinal Diseases Examples
Figure 11. CVS Diseases Examples
Figure 12. Others Examples
Figure 13. Global Orally Disintegrating Tablet Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Orally Disintegrating Tablet Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Orally Disintegrating Tablet Sales Quantity (2018-2029) & (M Units)
Figure 16. Global Orally Disintegrating Tablet Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Orally Disintegrating Tablet Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Orally Disintegrating Tablet Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Orally Disintegrating Tablet by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Orally Disintegrating Tablet Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Orally Disintegrating Tablet Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Orally Disintegrating Tablet Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Orally Disintegrating Tablet Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Orally Disintegrating Tablet Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Orally Disintegrating Tablet Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Orally Disintegrating Tablet Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Orally Disintegrating Tablet Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Orally Disintegrating Tablet Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Orally Disintegrating Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Orally Disintegrating Tablet Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Orally Disintegrating Tablet Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Orally Disintegrating Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Orally Disintegrating Tablet Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Orally Disintegrating Tablet Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Orally Disintegrating Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Orally Disintegrating Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Orally Disintegrating Tablet Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Orally Disintegrating Tablet Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Orally Disintegrating Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Orally Disintegrating Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Orally Disintegrating Tablet Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Orally Disintegrating Tablet Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Orally Disintegrating Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Orally Disintegrating Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Orally Disintegrating Tablet Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Orally Disintegrating Tablet Consumption Value Market Share by Region (2018-2029)
Figure 55. China Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Orally Disintegrating Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Orally Disintegrating Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Orally Disintegrating Tablet Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Orally Disintegrating Tablet Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Orally Disintegrating Tablet Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Orally Disintegrating Tablet Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Orally Disintegrating Tablet Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Orally Disintegrating Tablet Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Orally Disintegrating Tablet Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Orally Disintegrating Tablet Market Drivers
Figure 76. Orally Disintegrating Tablet Market Restraints
Figure 77. Orally Disintegrating Tablet Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Orally Disintegrating Tablet in 2022
Figure 80. Manufacturing Process Analysis of Orally Disintegrating Tablet
Figure 81. Orally Disintegrating Tablet Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
